3D Global Biotech Inc. (6808) Stock Price & Analysis
6808 Stock Chart & Stats
- Day’s Range
- TWD 24.35 - TWD 26.90
- 52-Week Range
- TWD 22.45 - TWD 51.50
- Previous Close
- TWD 27.05
- Volume
- N/A
- Average Volume (3M)
- 92.42K
- Market Cap
- TWD 2.04B
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- TWD 497.11M
- Total Debt (Recent Filing)
- TWD 45.16M
- Price to Earnings (P/E)
- 138.9
- Beta
- 0.15
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jul 16, 2026
- Dividend Yield
- 0.50%
6808 FAQ
What was 3D Global Biotech Inc.’s price range in the past 12 months?
What is 3D Global Biotech Inc.’s market cap?
When is 3D Global Biotech Inc.’s upcoming earnings report date?
Is 3D Global Biotech Inc. overvalued?
Does 3D Global Biotech Inc. pay dividends?
What is 3D Global Biotech Inc.’s EPS estimate?
How many shares outstanding does 3D Global Biotech Inc. have?
Which hedge fund is a major shareholder of 3D Global Biotech Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
3D Global Biotech Inc.
Based in New Taipei City, China, 3D Global Biotech Inc. (3DGBI) specializes in the development of advanced medical materials designed for human body reconstruction. The company leverages sophisticated cell culture systems, cutting-edge 3D printing technology, and proprietary bio-inks hydrogel to create personalized, patient-specific cell-based medical products. Beyond product manufacturing, 3DGBI is dedicated to building platforms for human tissue and organ regeneration, engineering customized medical equipment, and undertaking significant professional research. Its extensive product range includes artificial bone substitutes, skull fixation systems, biological dressings, bio-inks, and bioprinting machinery. They also offer specialized solutions for orthopedic, dental, cranial, and scalp reconstruction. The company serves a broad spectrum of clients, including medical centers, research institutions, businesses, and distributors. 3DGBI actively fosters an interdisciplinary alliance, bringing together expertise from industry, government, academia, research, and medicine. It was established in 2014.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Keng-Liang Ou
- Employees
- 43
- Website
- www.3dglobalbiotech.com.tw
- Address
- No.99, Xintai 5th Road, New Taipei City, TP, 221, TW
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |

